These parameters are commonly monitored in the context of CKD-MBD and associated sequelae, generally with consistent monitoring intervals across clinical guidelines.KDIGO: serum calcium and phosphate tested every 1-3 months; PTH every 3-6 months; and ALP annually. Here, PTH is linked to Marchiafava-Bignami disease.